Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Sponsored by Cytiva
On 12 March 2015, BPI met with Mario Philips, president, single-use technologies, at Pall’s Port Washington, NY, facility, to learn about Pall’s reasons for entering the cell therapy market. Also participating in the discussion was Alain Fairbank, director of marketing for cell therapies at Pall Life Sciences.
Read the full text of this article in the PDF (Login required).
You May Also Like